Thus, FGF21 administration beneficially affected mice of both sexes despite obesity-associated sex differences in metabolic characteristics, and it induced female-specific activation of gene expression in WAT. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.